BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Lung cancer
,
Breast
,
Amniocentesis
,
Ciprofibrate
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ZAP 70
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Dexamethasone treatment of CLL cells with different IGHV/ZAP-70 statuses
B-cell Chronic Lymphocytic Leukemia: CD38 status and prognosis
Chronic lymphocytic leukemia B cells marked with IgVH mutation (mutIgVH) and ZAP70 expression
B cell chronic lymphocytic leukemia cells compared based on miR-150 expression
Spontaneous regression of CTL: clinical and biological features of 9 cases
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery and Structural Optimization of Covalent ZAP-70 Kinase Inhibitors against Psoriasis.
ZAP-70 mutation: a case with familial autoimmune haemolytic anaemia and immune deficiency.
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
The Ubiquitin-Associated and SH3 Domain-Containing Proteins (UBASH3) Family in Mammalian Development…
T cell receptor-dependent S-acylation of ZAP-70 controls activation of T cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL
Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Ly…
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic…
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed C…
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leuke…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ